US-Funded Vaccine Trial in Africa on Hold: Health Minister

Researchers want to analyze the hepatitis B vaccine in Guinea-Bissau.

A nurse loads a syringe with a vaccine against hepatitis in Lynwood, Calif., on Aug. 27, 2013. Robyn Beck/AFP via Getty Images

A vaccine trial partially funded by the United States is on hold pending a review, African officials announced on Jan. 22.

There is no record of an ethics committee meeting to review the trial, Guinea-Bissau’s Health Minister Quinhi Nantot said during a news conference held by the Africa Centers for Disease Control and Prevention.